This study is in progress, not accepting new patients
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Polaris Group
- ID
- NCT02709512
- Phase
- Phase 2/3 Mesothelioma Research Study
- Study Type
- Interventional
- Participants
- Expecting 386 study participants
- Last Updated